DocGo Inc. Depreciation
DocGo Inc. (DCGO) reported Depreciation of $1.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-17
- DocGo Inc. depreciation for the quarter ending 2026-06-30 was $1.24M, a 2.20% increase year-over-year.
- DocGo Inc. depreciation for the quarter ending 2026-03-31 was $1.27M, a 3.74% increase year-over-year.
- DocGo Inc. depreciation for the quarter ending 2025-12-31 was $1.18M, a 10.81% decline year-over-year.
- DocGo Inc. depreciation for the quarter ending 2025-09-30 was $1.25M, a 9.09% decline year-over-year.
- DocGo Inc. depreciation for fiscal 2025 was $4.86M, a 13.26% decline from fiscal 2024.
- DocGo Inc. depreciation for fiscal 2024 was $5.61M, a 16.09% increase from fiscal 2023.
- DocGo Inc. depreciation for fiscal 2023 was $4.83M, a 17.39% increase from fiscal 2022.
- DocGo Inc. depreciation for fiscal 2022 was $4.11M, a 77.92% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.24M 10-Q · filed 2026-08-17 | $2.50M 10-Q · filed 2026-08-17 | $3.69M derived: sum of 3 quarters · filed 2026-08-17 | $4.94M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $1.27M 10-Q · filed 2026-05-11 | $2.45M derived: sum of 2 quarters · filed 2026-05-11 | $3.70M derived: sum of 3 quarters · filed 2026-05-11 | $4.91M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.43M derived: sum of 2 quarters · filed 2026-03-16 | $3.64M derived: sum of 3 quarters · filed 2026-08-17 | $4.86M 10-K · filed 2026-03-16 |
| 2025-09-30 | $1.25M 10-Q · filed 2025-11-10 | $2.46M derived: sum of 2 quarters · filed 2026-08-17 | $3.68M 10-Q · filed 2025-11-10 | $5.01M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $1.21M 10-Q · filed 2026-08-17 | $2.43M 10-Q · filed 2026-08-17 | $3.76M derived: sum of 3 quarters · filed 2026-08-17 | $5.13M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $1.22M 10-Q · filed 2026-05-11 | $2.54M derived: sum of 2 quarters · filed 2026-05-11 | $3.92M derived: sum of 3 quarters · filed 2026-05-11 | $5.40M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.70M derived: sum of 2 quarters · filed 2026-03-16 | $4.18M derived: sum of 3 quarters · filed 2026-03-16 | $5.61M 10-K · filed 2026-03-16 |
| 2024-09-30 | $1.37M 10-Q · filed 2025-11-10 | $2.85M derived: sum of 2 quarters · filed 2025-11-10 | $4.28M 10-Q · filed 2025-11-10 | $4.42M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $1.48M 10-Q · filed 2025-08-07 | $2.91M 10-Q · filed 2025-08-07 | $3.04M derived: sum of 3 quarters · filed 2026-03-16 | $4.67M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $1.43M 10-Q · filed 2025-05-08 | $1.56M derived: sum of 2 quarters · filed 2026-03-16 | $3.19M derived: sum of 3 quarters · filed 2026-03-16 | $4.78M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $132.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.76M derived: sum of 2 quarters · filed 2026-03-16 | $3.35M derived: sum of 3 quarters · filed 2026-03-16 | $4.83M 10-K · filed 2026-03-16 |
| 2023-09-30 | $1.63M 10-Q · filed 2024-11-07 | $3.22M derived: sum of 2 quarters · filed 2024-11-07 | $4.70M 10-Q · filed 2024-11-07 | $6.22M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.59M 10-Q · filed 2024-08-07 | $3.07M 10-Q · filed 2024-08-07 | $4.59M derived: sum of 3 quarters · filed 2025-02-27 | $5.75M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.48M 10-Q · filed 2024-05-08 | $3.00M derived: sum of 2 quarters · filed 2025-02-27 | $4.16M derived: sum of 3 quarters · filed 2025-02-27 | $4.89M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.67M derived: sum of 2 quarters · filed 2025-02-27 | $3.40M derived: sum of 3 quarters · filed 2025-02-27 | $4.11M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.15M 10-Q · filed 2023-11-06 | $1.88M derived: sum of 2 quarters · filed 2023-11-06 | $2.59M 10-Q · filed 2023-11-06 | $3.21M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $729.56K 10-Q · filed 2023-08-08 | $1.44M 10-Q · filed 2023-08-08 | $2.06M derived: sum of 3 quarters · filed 2024-02-28 | $2.65M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $711.88K 10-Q · filed 2023-05-09 | $1.33M derived: sum of 2 quarters · filed 2024-02-28 | $1.93M derived: sum of 3 quarters · filed 2024-02-28 | $2.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $615.06K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.21M derived: sum of 2 quarters · filed 2024-02-28 | $1.78M derived: sum of 3 quarters · filed 2024-02-28 | $2.31M 10-K · filed 2024-02-28 |
| 2021-09-30 | $598.19K 10-Q · filed 2022-11-08 | $1.17M derived: sum of 2 quarters · filed 2022-11-08 | $1.70M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $570.35K 10-Q · filed 2022-08-09 | $1.10M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $528.84K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $1.87M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |